id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
APHIS-2011-0048-0059,APHIS,APHIS-2011-0048,"Viruses, Serums, Toxins, and Analogous Products: Unsuspended and Unrevoked License; Exemptions",Rule,Final Rule,2015-05-11T04:00:00Z,2015,5,2015-05-11T04:00:00Z,,2015-05-11T14:53:11Z,2015-11311,0,0,0900006481ad8c12
APHIS-2011-0048-0060,APHIS,APHIS-2011-0048,11-048-3 Econ Analysis,Supporting & Related Material,Economic Analysis,2015-05-11T04:00:00Z,2015,5,,,2015-05-11T14:53:56Z,,0,0,09000064819caf4d
APHIS-2011-0048-0050,APHIS,APHIS-2011-0048,"Viruses, Serums, Toxins, and Analogous Products: Exemptions from Preparation Pursuant to Unsuspended and Unrevoked License",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-09-20T04:00:00Z,2012,9,2012-09-20T04:00:00Z,2012-11-17T04:59:59Z,2012-11-14T03:06:44Z,2012-23202,0,0,090000648111ff93
APHIS-2011-0048-0001,APHIS,APHIS-2011-0048,"Viruses, Serums, Toxins, and Analogous Products: Exemptions from Preparation Pursuant to an Unsuspended and Unrevoked License",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2012-07-18T04:00:00Z,2012,7,2012-07-18T04:00:00Z,2012-11-17T04:59:59Z,2012-11-07T03:00:41Z,2012-17533,0,0,090000648109faf1